Ashland Commits to Major Capacity Expansion for Klucel™ Products

Expansion Aimed at Meeting Growing Customer Demand

Ashland is committed to the overall pharmaceutical market, and has made a number of sizeable investments over the past two years to strengthen our position.

Wilmington, Del. (PRWEB) August 07, 2014

Ashland Specialty Ingredients, a commercial unit of Ashland Inc. (NYSE: ASH), today announced plans to significantly expand production capacity of its Klucel™ hydroxypropylcellulose (HPC) product line in Hopewell, Va. The expansion is expected to begin production in the second half of calendar 2016. Klucel HPC is a tablet binder and coating ingredient used in pharmaceutical applications and dietary supplements worldwide.

“Ashland is committed to the overall pharmaceutical market, and has made a number of sizeable investments over the past two years to strengthen our position,” said David Neuberger, Vice President, Pharmaceutical Specialties, Ashland Specialty Ingredients.

Those investments include the opening of Ashland’s pharmaceutical center of excellence in Hyderabad, India earlier this year; the pending expansion of Ashland’s technical capabilities in Wilmington, Del.; and the Polyplasdone™ crospovidone expansion in Texas City, Texas.

Ashland Inc. (NYSE: ASH) is a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, personal care and pharmaceutical. Through our three commercial units – Ashland Specialty Ingredients, Ashland Performance Materials, and Valvoline – we use good chemistry to make great things happen for customers in more than 100 countries. Visit ashland.com to learn more.

® Registered trademark, Ashland or its subsidiaries, registered in various countries
TM Trademark, Ashland or its subsidiaries, registered in various countries